Progressive deterioration of β-cell function in obese youth with type 2 diabetes

Pediatric Diabetes

Volumn 14, Issue 2, 2013, Pages 106-111

  Bacha, Fida ^a,b   Gungor, Neslihan ^c   Lee, Sojung ^a   Arslanian, Silva A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

cell function; Insulin secretion; Youth type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ABDOMINAL OBESITY; ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GLUCONEOGENESIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; OBESITY, ABDOMINAL;

EID: 84874482538     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00915.x     Document Type: Article

References (21)

1. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes mellitus: insulin resistance, beta-cell failure or both? Diabetes Care 2005: 28: 638-644.
2. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab 2006: 91: 185-191.
3. Kahn S. Clinical review 135-the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001: 86: 4047-4058.
4. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet Med 1998: 15: 297-303.
5. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes 2005: 6: 95-99.
6. Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004: 144: 656-659.
7. Katz LE, Magge SN, Hernandez ML, Murphy KM, McKnight HM, Lipman T. Glycemic control in youth with type 2 diabetes declines as early as two years after diagnosis. J Pediatr 2011: 158: 106-111.
8. Ekholm E, Gottsäter A, Dahlin LB, Sundkvist G. No signs of progressive beta cell damage during 20 years of prospective follow-up of autoantibody-negative diabetes. Acta Diabetol 2012: 49: 57-62.
9. Bacha F, Pyle L, Nadeau K et al., The TODAY Study Group. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes 2012. In press. doi:10.1111.
10. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008: 359: 1577-1589.
11. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007: 26: 1823-1831.
12. Eppens MC, Craig ME, Cusumano J et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006: 29: 1300-1306.
13. Ruhayel SD, James RA, Ehtisham S, Cameron FJ, Werther GA, Sabin MA. An observational study of type 2 diabetes within a large Australian tertiary hospital pediatric diabetes service. Pediatr Diabetes 2010: 11: 544-551.
14. Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes 2009: 58: 738-744.
15. Bacha F, Gungor N, Lee S, Arslanian S. In vivo insulin sensitivity and secretion in obese youth: what are the differences between NGT, IGT and type 2 diabetes? Diabetes Care 2009: 32: 100-105.
16. Bacha F, Saad R, Gungor N, Arslanian S. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004: 27: 547-552.
17. Bacha F, Gungor N, Lee S, Arslanian S. Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes 2012: 13: 259-265.
18. Kahn SE, Lachin JM, Zinman B et al., ADOPT Study Group. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes 2011: 60: 1552-1560.
19. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002: 51: 1754-1762.
20. Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy Marchal C. Characterization of insulin secretion and resistance in type 2 diabetes of adolescence. J Clin Endocrinol Metab 2006: 91: 401-404.
21. Zeitler P, Epstein L, Grey M et al., TODAY Study Group. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007: 8: 74-87.